2016
DOI: 10.1016/j.ejmech.2016.06.034
|View full text |Cite
|
Sign up to set email alerts
|

3-Hydrazinoindolin-2-one derivatives: Chemical classification and investigation of their targets as anticancer agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
13
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 27 publications
(13 citation statements)
references
References 79 publications
0
13
0
Order By: Relevance
“…Some derivatives have attracted much attentions because they are regarded as new anticancer agents [4][5][6][7]. Recently, our group synthesized two platinum(II) complexes with methyl hydrazinecarbodithioate derivatives of indolin-2-one, which can non-covalently bind to DNA with high affinity and exhibit cytotoxicity against cancer cells by inducing apoptosis [8].…”
Section: Discussionmentioning
confidence: 99%
“…Some derivatives have attracted much attentions because they are regarded as new anticancer agents [4][5][6][7]. Recently, our group synthesized two platinum(II) complexes with methyl hydrazinecarbodithioate derivatives of indolin-2-one, which can non-covalently bind to DNA with high affinity and exhibit cytotoxicity against cancer cells by inducing apoptosis [8].…”
Section: Discussionmentioning
confidence: 99%
“…For example, studies have shown that certain isatin derivatives can significantly inhibit endothelial growth factor receptor (EGFR) activity, 6 migration and angiogenesis, 7 as well as vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR) and Kit receptor families. 8 Additionally, some of these derivatives, such as sunitinib, have been developed as antitumor drugs. Furthermore, synthetic indolediones suppress the activity of protein tyrosine kinases (PTKs) related to growth factor receptors and cell proliferation.…”
Section: Introductionmentioning
confidence: 99%
“…Indolin-2-one derivatives exhibit promising antitumor activity by targeting different biomacromolecules [5,6], of which 3-hydrazinoindolin-2-one derivatives have particularly attracted intensive attention [7,8]. In our previous work, methyl hydrazinecarbodithioate derivatives of 5-fluoro-1-(2-morpholinoethyl)indolin-2-one and 5-methoxy-1-(2-morpholinoethyl)indolin-2-one were used as ligands to achieve two new Pt(II) complexes, which exhibited cytotoxicity against cancer cells by inducing apoptosis [9].…”
Section: Discussionmentioning
confidence: 99%